Phibro Animal Health (PAHC) Price to Sales (2014 - 2026)

Phibro Animal Health has reported Price to Sales for 13 years, with the latest figure at 3.21 in Q2 2026.

• On a quarterly basis, Price to Sales rose 17.44% year-over-year to 3.21 in Q2 2026; TTM through Jun 2026 was 0.84, a 5.06% increase from a year earlier, with the FY2026 full-year figure at 0.84, up 5.06% from the prior year.
• Price to Sales was 3.21 for Q2 2026 at Phibro Animal Health, down from 5.85 in the prior quarter.
• The five-year high for Price to Sales was 5.85 in Q1 2026, with the low at 1.88 in Q4 2023.
• Average Price to Sales over 5 years is 2.96, with a median of 2.63 recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Price to Sales slumped 43.04% in 2022, then surged 135.01% in 2026.
• Over 5 years, Price to Sales stood at 2.22 in 2022, then declined by 15.48% to 1.88 in 2023, then surged by 46.56% to 2.75 in 2024, then jumped by 47.25% to 4.05 in 2025, then decreased by 20.77% to 3.21 in 2026.
• The last three Price to Sales figures came in at 3.21 (Q2 2026), 5.85 (Q1 2026), and 4.05 (Q4 2025), per Business Quant data.